Science, Health & Medicine
The Psychedelic Therapeutics and Drug Development Conference is bringing together the world’s leading researchers in academia and industry to share novel research into psychedelic drug development.
The Psychedelic Therapeutics and Drug Development Conference has been organized to bring together the world’s leading researchers and leaders in academia and industry to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.
Clinical trial design
Risk Evaluation & Mitigation Strategy (REMS)
DEA licensure & policy considerations
Targets for novel drug development
Second generation psychedelic drug design
FDA regulatory guidance
Toxicology studies and considerations
Industry - USD 450.0
Academic - USD 250.0
Non-Profit - USD 250.0
Government - USD 250.0
Student - USD 150.0